Raub Brock Capital Management’s DexCom DXCM Stock Holding History

Raub Brock Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,355	Closed	-$292K	–	48
2023 Q4	$292K	Buy	+2,355	New	+$241K	0.06%	60
2023 Q3	–	Sell	-1,980	Closed	-$254K	–	64
2023 Q2	$254K	Hold	1,980	–	–	0.05%	63
2023 Q1	$230K	Hold	1,980	–	–	0.04%	63
2022 Q4	$224K	Buy	+1,980	New	+$217K	0.05%	60
2022 Q2	–	Sell	-1,980	Closed	-$253K	–	70
2022 Q1	$253K	Sell	1,980 -800	-29%	-$87.5K	0.04%	66
2021 Q4	$380K	Hold	2,780	–	–	0.06%	45
2021 Q3	$380K	Hold	2,780	–	–	0.06%	45
2021 Q2	$297K	Hold	2,780	–	–	0.05%	41
2021 Q1	$250K	Hold	2,780	–	–	0.04%	56
2020 Q4	$257K	Buy	+2,780	New	+$248K	0.04%	50

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Raub Brock Capital Management's DXCM Position: Q1 2024 in Review

Raub Brock Capital Management sold out of DexCom (DXCM) in Q1 2024, closing a stake of 2,355 shares — an estimated $292K sold.

Raub Brock Capital Management first reported a position in DXCM in Q4 2020 and held it in 10 quarters. The position peaked at $380K in Q4 2021. 1,032 funds tracked by Wall St. Rank hold DXCM as of Q1 2024.

Raub Brock Capital Management reported no remaining DexCom position as of Q1 2024 after selling out during the quarter.
Raub Brock Capital Management sold 2,355 DexCom shares in Q1 2024, an estimated $292K.
Raub Brock Capital Management first reported a position in DexCom in Q4 2020 and held it in 10 quarters.
Raub Brock Capital Management's DexCom position peaked at $380K in Q4 2021.
1,032 funds tracked by Wall St. Rank held DexCom as of Q1 2024.

Based on Raub Brock Capital Management's 13F filing for Q1 2024, filed 18 Apr 2024.